Major gene study seeks to unlock why some prostate cancers are more aggressive
NCT ID NCT02705846
Summary
This study aims to understand how prostate cancer progresses in men who have specific inherited gene mutations (like BRCA1/BRCA2) that increase their risk. It will follow over 4,000 men, comparing outcomes for those with and without these mutations. The goal is to gather critical information to help design better, more personalized treatment plans for high-risk patients in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Institute of Cancer Research and Royal Marsden Hospital
RECRUITINGSutton, Surrey, SM2 5PT, United Kingdom
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.